In particular, meloxicam 7.5 mg/day was associated with a lower incidence of gastrointestinal adverse events compared with diclofenac (13% vs 19%; p < 0.001) or piroxicam (10.3% vs 15.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback